The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant AstraZeneca for the advanced optimization of clinical trials.
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Kahun’s new AI Agent is revolutionizing healthcare by providing real-time, patient-specific medical insights, helping doctors stay updated on pharmaceutical developments while improving patient care.
Mounjaro is a new-generation injection that mimics two hormones in the body: GLP-1 and GIP. These hormones influence several processes in the body, including blood sugar regulation and satiety.
The Knesset Health Committee approved ordinances for the Pharmacists’ Regulations that would expand the list of active ingredients in drugs to be sold without a prescription and outside pharmacies
Lifestyle medicine prevents and reverses many chronic conditions and even auto-immune ones.
The companies have denied wrongdoing and said they "are not responsible in any way for the tragic events that were caused and carried out by Iraqi militia groups."
After years of financial and legal problems, Israel’s Teva Pharmaceutical Industries Ltd. named No.19 among the world’s top 20 best-earning pharmaceutical companies.
The hotline, which had previously functioned only for emergencies, will reopen for expanded assistance starting this week.
JPOST Digital Library
